Clinical Trial Update: Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials (SURROGATE-ICI)

View source ↗

Summary

The update reports results from the SURROGATE-ICI study evaluating surrogate endpoints in cancer trials involving immune-checkpoint inhibitors, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Institut Bergonié | Conditions: Cancer Treated With Immune-checkpoint Inhibitors | Status: COMPLETED | Results posted: 2025-09-15